Table 1.
Backgrounds of participants.
| SP | PAA | p-value | |
|---|---|---|---|
| Age (years) | 76.7 ± 6.9 | 76.1 ± 4.7 | 0.142 |
| Height (cm) | 168.3 ± 3.6 | 167.2 ± 4.9 | 0.177 |
| Body weight (kg) | 69.1 ± 8.9 | 68.3 ± 6.9 | 0.467 |
| BMI (kg/m2) | 23.8 ± 2.7 | 24.9 ± 2.3 | 0.267 |
| P-EW (cc) | 29.2 ± 8.4 | 31.1 ± 9.8 | 0.423 |
| IPSS | |||
| Total | 13.4 ± 5.5 | 14.5 ± 6.2 | 0.182 |
| Storage | 6.2 ± 2.5 | 8.1 ± 2.9 | 0.114 |
| Voiding | 7.3 ± 4.3 | 8.4 ± 4.3 | 0.974 |
| QOL | 4.0 ± 1.1 | 4.0 ± 0.9 | 0.228 |
| OABSS | 4.9 ± 2.5 | 6.8 ± 3.3 | 0.706 |
| IIEF5 | 1.2 ± 0.5 | 1.4 ± 0.5 | 0.453 |
| ICIQ-SF | 1.9 ± 3.2 | 5.3 ± 4.9 | 0.197 |
| UFM | |||
| RV (ml) | 30.8 ± 22.3 | 36.4 ± 21.5 | 0.655 |
| Qmax (ml/s) | 13.3 ± 6.8 | 12.6 ± 6.7 | 0.187 |
| 8-OHdG (ng/mlCRE) | 18.4 ± 8.2 | 17.4 ± 5.4 | 0.725 |
*p-value, estimated probability of rejecting the null hypothesis.
Notes: P-EW, prostate estimate weight; QOL, quality of life; OABSS, Overactive Bladder Symptom Score; IPSS, International Prostate Symptom Score; IIEF5, 5-item version of the International Index of Erectile Function; ICIQ-SF, Consultation on Incontinence Questionnaire e-short Form; UFM, uroflowmetry; RV, residual urine volume; Qmax, maximum flow rate; 8OHdG, 8-hydroxy-2’-deoxyguanosine.